These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26668317)

  • 21. Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme.
    Escrevente C; Morais VA; Keller S; Soares CM; Altevogt P; Costa J
    Biochim Biophys Acta; 2008 Jun; 1780(6):905-13. PubMed ID: 18381078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
    Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
    J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.
    Marcello E; Saraceno C; Musardo S; Vara H; de la Fuente AG; Pelucchi S; Di Marino D; Borroni B; Tramontano A; Pérez-Otaño I; Padovani A; Giustetto M; Gardoni F; Di Luca M
    J Clin Invest; 2013 Jun; 123(6):2523-38. PubMed ID: 23676497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor.
    Arduise C; Abache T; Li L; Billard M; Chabanon A; Ludwig A; Mauduit P; Boucheix C; Rubinstein E; Le Naour F
    J Immunol; 2008 Nov; 181(10):7002-13. PubMed ID: 18981120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.
    Deng W; Cho S; Su PC; Berger BW; Li R
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15987-92. PubMed ID: 25349418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An arginine stretch limits ADAM10 exit from the endoplasmic reticulum.
    Marcello E; Gardoni F; Di Luca M; Pérez-Otaño I
    J Biol Chem; 2010 Apr; 285(14):10376-84. PubMed ID: 20100836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.
    Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC
    J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
    Barbaud A; Lascombe I; Péchery A; Arslan S; Kleinclauss F; Fauconnet S
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases.
    Bender M; Hofmann S; Stegner D; Chalaris A; Bösl M; Braun A; Scheller J; Rose-John S; Nieswandt B
    Blood; 2010 Oct; 116(17):3347-55. PubMed ID: 20644114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for membrane-proximal proteolysis of substrates by ADAM10.
    Lipper CH; Egan ED; Gabriel KH; Blacklow SC
    Cell; 2023 Aug; 186(17):3632-3641.e10. PubMed ID: 37516108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-Disintegrin-And-Metalloproteinase (ADAM) 10 Activity on Resting and Activated Platelets.
    Facey A; Pinar I; Arthur JF; Qiao J; Jing J; Mado B; Carberry J; Andrews RK; Gardiner EE
    Biochemistry; 2016 Mar; 55(8):1187-94. PubMed ID: 26840909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.
    Janes PW; Saha N; Barton WA; Kolev MV; Wimmer-Kleikamp SH; Nievergall E; Blobel CP; Himanen JP; Lackmann M; Nikolov DB
    Cell; 2005 Oct; 123(2):291-304. PubMed ID: 16239146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
    Speck N; Brandsch C; Schmidt N; Yazdekhasti N; Hirche F; Lucius R; Rimbach G; Stangl GI; Reiss K
    J Nutr; 2015 Jun; 145(6):1218-26. PubMed ID: 25926412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).
    Houri N; Huang KC; Nalbantoglu J
    PLoS One; 2013; 8(8):e73296. PubMed ID: 24015300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seeing your partner: Structural elucidation of the first C8 tetraspanin protein.
    Binger KJ; Wright MD
    Structure; 2022 Feb; 30(2):203-205. PubMed ID: 35120595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM10 negatively regulates neuronal differentiation during spinal cord development.
    Yan X; Lin J; Talabattula VA; Mußmann C; Yang F; Wree A; Rolfs A; Luo J
    PLoS One; 2014; 9(1):e84617. PubMed ID: 24404179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.
    Caescu CI; Jeschke GR; Turk BE
    Biochem J; 2009 Oct; 424(1):79-88. PubMed ID: 19715556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
    Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
    J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
    Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
    PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.